Oxygen scavenging, NADH oxidase and metronidazole resistance in helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 347-353

  Smith, Mark A ^a,b   Edwards, David I ^a  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; METRONIDAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; ENZYME ACTIVITY; HELICOBACTER PYLORI; NONHUMAN;

ANTI-BACTERIAL AGENTS; CELL COUNT; DRUG RESISTANCE, MICROBIAL; HELICOBACTER PYLORI; METRONIDAZOLE; MULTIENZYME COMPLEXES; MUTATION; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0030898355     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.347     Document Type: Article

References (39)

1. Blaser, M. J. (1992), Heliobacter pylori: its role in disease. Clinical Infectious Diseases 15, 386-91.
2. NIH Consensus Development Panel. (1994). Helicobacter pylori in peptic ulcer disease. Journal of the American Medical Association 272, 65-9.
3. EUROGAST Study Group. (1993). An international association between Helicobacter pylori infection and gastric cancer. Lancet 341, 1359-62.
4. Glupczynski, Y. & Burette, A. (1992). Eradicating Helicobacter pylori. Lancet 339, 54-5.
5. Rautelin, H., Seppälä, K., Renkonen, O.-V., Vainio, U. & Kosunen, T. U. (1992). Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrobial Agents and Chemotherapy 36, 163-6.
6. Noach, L. A., Langenberg, W. L., Bertola, M. A., Dankert, J. & Tytgat, G. N. J. (1994). Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scandinavian Journal of Infectious Diseases 26, 321-7.
7. Rautelin, H., Tee, W., Seppälä, K. & Kosunen, T. U. (1994). Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. Journal of Clinical Microbiology 32, 1079-82.
8. Banatvala, N., Davies, G. R., Abdi, Y., Clements, L., Rampton, D. S., Hardie, J. M. et al. (1994). High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 35, 1562-6.
9. Cederbrant, G., Kahlmeter, G. & Ljungh, A. (1992). Proposed mechanism for metronidazole resistance in Helicobacter pylori. Journal of Antimicrobial Chemotherapy 29, 115-20.
10. Smith, M. A. & Edwards, D. I. (1995). Redox potential and oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocyclic drugs. Journal of Antimicrobial Chemotherapy 35, 751-64.
11. Smith, M. A. & Edwards, D. I. (1995). The influence of microaerophilia and anaerobosis on metronidazole uptake in Helicobacter pylori. Journal of Antimicrobial Chemotherapy 36, 453-61.
12. Doyle, J. J. & Doyle, J. L. (1990). Isolation of plant DMA from fresh tissue. Focus 12, 13-5.
13. Anders, R. F., Hogg, D. M. & Jago, G. R. (1970). Formation of hydrogen peroxide by group N streptococci and its effect on their growth and metabolism. Applied Microbiology 19, 608-12.
14. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-75.
15. Majewski, S. I. H. & Goodwin, G. S. (1988). Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation. Journal of Infectious Diseases 157, 465-71.
16. Akopyanz, N., Bukanov, N. O., Westblom, T. U., Kresovich, S. & Berg, D. E. (1992). DMA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Research 20, 5137-42.
17. O'Brien, R. W. & Morris, J. G. (1971). Oxygen and the growth and metabolism of Clostridium acetobutylicum. Journal of General Microbiology 68, 307-18.
18. Hoshino, E., Frölander, F. & Carlsson, J. (1978). Oxygen and the metabolism of Peptostreptococcus anaerobius VPI4330-1. Journal of General Microbiology 107, 235-48.
19. Koike, K., Kobayashi, T., Ito, S. & Saitoh, M. (1985). Purification and characterization of NADH oxidase from a strain of Leuconostoc mesenteroides. Journal of Biochemistry 97, 1279-88.
20. Saeki, Y., Nozaki, M. & Matsumoto, K. (1985). Purification and properties of NADH oxidase from Bacillus megaterium. Journal of Biochemistry 98, 1433-40.
21. 2O-forming NADH oxidase from Streptococcus faecalis. European Journal of Biochemistry 156, 149-55.
22. Park, H.-J., Reiser, C. O. A., Kondruweit, S., Erdmann, H., Schmid, R. D. & Sprinzl, M. (1992). Purification and characterization of a NADH oxidase from the thermophile Thermus thermophilus HB8. European Journal of Biochemistry 205, 881-5.
23. 2O-forming oxidase induced in Streptococcus mutans. Journal of General Microbiology 139, 2343-51.
24. Condon, S. (1987). Responses of lactic acid bacteria to oxygen. FEMS Microbiology Reviews 46, 269-80.
25. Edwards, D. I. (1993). Nitroimidazole drugs - action and resistance mechanisms. I. Mechanisms of action. Journal of Antimicrobial Chemotherapy 31, 9-20.
26. Smibert, R. M. (1978). The genus Campylobacter, Annual Review of Microbiology 32, 673-709.
27. Baer, W., Koopmann, H. & Wagner, S. (1993). Effects of substances inhibiting or uncoupling respiratory-chain phosphorylation of Helicobacter pylori. International Journal of Medical Microbiology, Virology, Parasitology and Infectious Diseases 280, 253-8.
28. Mendz, G. L., Hazell, S. L. & van Gorkom, L. (1994). Pyruvate metabolism in Helicobacter pylori. Archives of Microbiology 162, 187-92.
29. 13C NMR spectroscopy. Microbiology 140, 2085-92.
30. Mendz, G. L. & Hazell, S. L. (1993). Fumarate catabolism in Helicobacter pylori. Biochemistry and Molecular Bioiogy International 31, 325-32.
31. Hof, H., Rieffert, M., Sticht-Groh, V., Zak, O. & Schweizer, E. H. (1984). Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli. Antimicrobial Agents and Chemotherapy 26, 498-500.
32. Hughes, N. J., Chalk, P. A., Clayton, C. L. & Kelly, D. J. (1995). Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate:flavodoxin oxidoreductase from Helicobacter pylori. Journal of Bacteriology 177, 3953-9.
33. Kabícková, H., Kulda, J., Cerkasovová, A. & Pecková, H. (1986). Metronidazole resistant Tritichomonas foetus: activities of hydrogenosomal enzymes in course of development of anaerobic resistance. Acta Universitatis Carolinae, Biologica 30, 516-9.
34. Cerkasovová, A., Novák, J., Cerkasov, J., Kulda, J. & Tachezy, J. (1986). Metabolic properties of Trichomonas vaginalis resistant to metronidazole under anaerobic conditions. Acta Universitatis Carolinae, Biologica 30, 505-12.
35. Quon, D. V. K., d'Oliveira, C. E. & Johnson, P. J. (1992). Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proceedings of the National Academy of Sciences of the United States of America 89, 4402-6.
36. Daucher, J. A. & Krieg, N. R. (1995). Pyruvate:ferredoxin oxidoreductase in Campylobacter species. Canadian Journal of Microbiology 41, 198-201.
37. Tachezy, J., Kulda, J. & Tomková, E. (1993). Aerobic resistance in Trichomonas vaginalis to metronidazole induced in vitro. Parasitology 106, 31-7.
38. Yarlett, N., Yarlett, N. C. & Lloyd, D. (1986). Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities. Molecular and Biochemical Parasitology 19, 111-6.
39. Wilhelmsen, I., Weberg, R., Berstad, K., Hausken, T., Hundal, Ø, & Berstad, A. (1994). Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepato-Gastroenterology 41, 43-7.